NUDT9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.856000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.091600E-01
Normal-vs-Stage2
7.070400E-01
Normal-vs-Stage3
7.915400E-01
Normal-vs-Stage4
9.741200E-01
Stage1-vs-Stage2
2.216200E-01
Stage1-vs-Stage3
3.120200E-01
Stage1-vs-Stage4
4.780600E-01
Stage2-vs-Stage3
9.360400E-01
Stage2-vs-Stage4
6.126000E-01
Stage3-vs-Stage4
7.516000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.769200E-01
Normal-vs-AfricanAmerican
5.666200E-01
Normal-vs-Asian
4.498800E-01
Caucasian-vs-AfricanAmerican
5.271000E-01
Caucasian-vs-Asian
1.866350E-01
AfricanAmerican-vs-Asian
6.003800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.189800E-01
Normal-vs-Female
8.998600E-01
Male-vs-Female
3.700400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.782000E-01
Normal-vs-Age(41-60Yrs)
8.093800E-01
Normal-vs-Age(61-80Yrs)
8.697000E-01
Normal-vs-Age(81-100Yrs)
8.125400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.542000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.343800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.332800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.323980E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.434400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.682200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.799000E-01
Normal-vs-Daily Drinker
5.215400E-01
Normal-vs-Weekly Drinker
3.489600E-01
Normal-vs-Occasional Drinker
7.293400E-01
Normal-vs-Social Drinker
7.614400E-01
Non Drinker-vs-Daily Drinker
8.850600E-01
Non Drinker-vs-Weekly Drinker
4.052800E-01
Non Drinker-vs-Occasional Drinker
1.040440E-01
Non Drinker-vs-Social Drinker
2.775000E-01
Daily Drinker-vs-Weekly Drinker
4.711200E-01
Daily Drinker-vs-Occasional Drinker
8.965800E-02
Daily Drinker-vs-Social Drinker
2.597000E-01
Weekly Drinker-vs-Occasional Drinker
3.748300E-02
Weekly Drinker-vs-Social Drinker
1.746950E-01
Occasional Drinker-vs-Social Drinker
7.900000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.560600E-01
Normal-vs-Grade 2
2.005200E-01
Normal-vs-Grade 3
1.849010E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.395900E-02
Grade 1-vs-Grade 3
1.795800E-01
Grade 1-vs-Grade 4
3.560600E-01
Grade 2-vs-Grade 3
4.131000E-01
Grade 2-vs-Grade 4
2.005200E-01
Grade 3-vs-Grade 4
1.849010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.889600E-01
Normal-vs-NonDiabetic
9.181800E-01
Diabetic-vs-NonDiabetic
2.379800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.961800E-01
Normal-vs-NoPancreatitis
9.947800E-01
Pancreatitis-vs-NoPancreatitis
7.264300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.674800E-01
Normal-vs-N1
8.507800E-01
N0-vs-N1
3.141400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.579600E-01
Normal-vs-TP53-NonMutant
6.428000E-01
TP53-Mutant-vs-TP53-NonMutant
6.110300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
